Tissue ablation after 120W greenlight laser vaporization and bipolar plasma vaporization of the prostate: a comparison using transrectal three-dimensional ultrasound volumetry

Introduction and objectives: Greenlight laser vaporization (LV) of the prostate is characterized by simultaneous vaporization and coagulation of prostatic tissue resulting in tissue ablation together with excellent hemostasis during the procedure. It has been reported that bipolar plasma vaporization (BPV) of the prostate might be an alternative for LV. So far, it has not been shown that BPV is as effective as LV in terms of tissue ablation or hemostasis. We performed transrectal three-dimensional ultrasound investigations to compare the efficiency of tissue ablation between LV and BPV. Methods: Between 11.2009 and 5.2011, 50 patients underwent pure BPV in our institution. These patients were matched with regard to the pre-operative prostate volume to 50 LV patients from our existing 3D-volumetry-database. Transrectal 3D ultrasound and planimetric volumetry of the prostate were performed pre-operatively, after catheter removal, 6 weeks and 6 months. Results: Median pre-operative prostate volume was not significantly different between the two groups (45.3ml vs. 45.4ml; p=1.0). After catheter removal, median absolute volume reduction (BPV 12.4ml, LV 6.55ml) as well as relative volume reduction (27.8% vs. 16.4%) were significantly higher in the BPV group (p<0.001). After six weeks (42.9% vs. 33.3%) and six months (47.2% vs. 39.7%), relative volume reduction remained significantly higher in the BPV group (p<0.001). Absolute volume reduction was non-significantly higher in the BPV group after six weeks (18.4ml, 13.8ml; p=0.051) and six months (20.8ml, 18ml; p=0.3). Clinical outcome parameters improved significantly in both groups without relevant differences between the groups. Conclusions: Both vaporization techniques result in efficient tissue ablation with initial prostatic swelling. BPV seems to be superior due to a higher relative volume reduction. This difference had no clinical impact after a follow-up of 6M.

[1]  Qi Chen,et al.  Bipolar transurethral resection in saline vs traditional monopolar resection of the prostate: results of a randomized trial with a 2‐year follow‐up , 2010, BJU international.

[2]  Alexander Bachmann,et al.  Morbidity, mortality and early outcome of transurethral resection of the prostate: a prospective multicenter evaluation of 10,654 patients. , 2008, The Journal of urology.

[3]  Scott Van Appledorn,et al.  A randomized trial of photoselective vaporization of the prostate using the 80‐W potassium‐titanyl‐phosphate laser vs transurethral prostatectomy, with a 1‐year follow‐up , 2010, BJU international.

[4]  B. Geavlete,et al.  Bipolar plasma vaporization vs monopolar and bipolar TURP-A prospective, randomized, long-term comparison. , 2011, Urology.

[5]  A. De la taille,et al.  Transurethral plasma vaporization of the prostate: 3‐month functional outcome and complications , 2012, BJU international.

[6]  A. Al-Ansari,et al.  GreenLight HPS 120-W laser vaporization versus transurethral resection of the prostate for treatment of benign prostatic hyperplasia: a randomized clinical trial with midterm follow-up. , 2010, European urology.

[7]  M. Emberton,et al.  Guidelines on the Treatment of Non-neurogenic Male LUTS , 2011 .

[8]  V. Hernández,et al.  GreenLight HPS 120-W laser vaporization versus transurethral resection of the prostate for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia: a randomized clinical trial with 2-year follow-up. , 2011, European urology.

[9]  R G Aarnink,et al.  Reproducibility of prostate volume measurements from transrectal ultrasonography by an automated and a manual technique. , 1996, British journal of urology.

[10]  C. Stief,et al.  Techniques and long-term results of surgical procedures for BPH. , 2006, European urology.

[11]  C. Iselin,et al.  High‐power potassium‐titanyl‐phosphate laser fibres for endovaporization of benign prostatic hyperplasia: how much do they deteriorate during the procedure? , 2011, BJU international.

[12]  B. Geavlete,et al.  Transurethral resection (TUR) in saline plasma vaporization of the prostate vs standard TUR of the prostate: ‘the better choice’ in benign prostatic hyperplasia? , 2010, BJU international.

[13]  S. Kaplan,et al.  Photoselective laser vaporization prostatectomy in men receiving anticoagulants. , 2005, Journal of endourology.

[14]  T. Gasser,et al.  GreenLight laser vaporization of the prostate: single-center experience and long-term results after 500 procedures. , 2008, European urology.

[15]  H. Woo,et al.  GreenLight HPS 120-W Laser for Benign Prostatic Hyperplasia: Comparative Complications and Technical Recommendations , 2008 .

[16]  T. Hermanns,et al.  Lithium triborate laser vaporization of the prostate using the 120 W, high performance system laser: high performance all the way? , 2009, The Journal of urology.

[17]  D. Bostwick,et al.  High-power (60-watt) potassium-titanyl-phosphate laser vaporization prostatectomy in living canines and in human and canine cadavers. , 1997, Urology.

[18]  D. Coomans,et al.  Conventional monopolar resection or bipolar resection in saline for the management of large (>60 g) benign prostatic hyperplasia: An evaluation of morbidity , 2010, Minimally invasive therapy & allied technologies : MITAT : official journal of the Society for Minimally Invasive Therapy.

[19]  T. Hermanns,et al.  Laser fibre deterioration and loss of power output during photo-selective 80-w potassium-titanyl-phosphate laser vaporisation of the prostate. , 2009, European urology.

[20]  H. Son,et al.  Current Laser Treatments for Benign Prostatic Hyperplasia , 2010, Korean journal of urology.

[21]  Tullio Sulser,et al.  High power (80 W) potassium-titanyl-phosphate laser vaporization of the prostate in 66 high risk patients. , 2005, The Journal of urology.

[22]  R. Hahn,et al.  Complications and clinical outcome 18 months after bipolar and monopolar transurethral resection of the prostate. , 2011, Journal of endourology.

[23]  C. Stief,et al.  Plasma vaporisation of the prostate: initial clinical results. , 2010, European urology.

[24]  M. Srougi,et al.  Transurethral resection of the prostate for the treatment of lower urinary tract symptoms related to benign prostatic hyperplasia: how much should be resected? , 2009, International braz j urol : official journal of the Brazilian Society of Urology.

[25]  Kurt Lehmann,et al.  Photoselective vaporization (PVP) versus transurethral resection of the prostate (TURP): a prospective bi-centre study of perioperative morbidity and early functional outcome. , 2005, European urology.

[26]  Tullio Sulser,et al.  Ablative efficiency of lithium triborate laser vaporization and conventional transurethral resection of the prostate: a comparison using transrectal three-dimensional ultrasound volumetry , 2011, BiOS.

[27]  W. Cai,et al.  Evaluation of greenlight photoselective vaporization of the prostate for the treatment of high-risk patients with benign prostatic hyperplasia. , 2006, Asian journal of andrology.